TY - JOUR
T1 - The Chicago Consensus Guidelines for Peritoneal Surface Malignancies
T2 - Introduction
AU - Chicago Consensus Working Group
AU - Turaga, Kiran
AU - Ahuja, Nita
AU - Richard Alexander, H.
AU - Abbott, Daniel E.
AU - Badgwell, Brian
AU - Baumgartner, Joel M.
AU - Choudry, M. Haroon A.
AU - Cusack, James C.
AU - Deneve, Jeremiah L.
AU - Esquivel, Jesus
AU - Foster, Jason M.
AU - Hanna, Nader
AU - Hayes-Jordan, Andrea
AU - Johnston, Fabian M.
AU - Labow, Daniel M.
AU - Lambert, Laura A.
AU - Lee, Byrne
AU - Levine, Edward A.
AU - Lowy, Andrew M.
AU - Nash, Garrett M.
AU - Staley, Charles
AU - Votanopoulos, Konstantinos I.
AU - Senthil, Maheswari
AU - Sugarbaker, Paul H.
AU - Diane Yamada, S.
AU - Bartlett, David L.
N1 - Funding Information:
Nita Ahuja reports grant funding from Cepheid and Astex, has served as a consultant to Ethicon, and has licensed methylation biomarkers to Cepheid. James C. Cusack reports grants from Lumicell Inc. outside the submitted work. Jesus Esquivel reports personal fees from Eight Medical. Garrett M. Nash reports non-financial support from Intuitive outside the submitted work. The remaining authors disclosed no conflicts of interest.
Publisher Copyright:
© 2020, American Cancer Society and Society of Surgical Oncology.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of peritoneal surface malignancies of various causes. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence. This article serves as an introduction to this effort.
AB - The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of peritoneal surface malignancies of various causes. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence. This article serves as an introduction to this effort.
UR - http://www.scopus.com/inward/record.url?scp=85083322250&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083322250&partnerID=8YFLogxK
U2 - 10.1245/s10434-020-08318-8
DO - 10.1245/s10434-020-08318-8
M3 - Article
C2 - 32285277
AN - SCOPUS:85083322250
SN - 1068-9265
VL - 27
SP - 1737
EP - 1740
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 6
ER -